Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Cancer Cell

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    February 2017
  1. GARDNER EE, Lok BH, Schneeberger VE, Desmeules P, et al
    Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
    Cancer Cell. 2017;31:286-299.
    PubMed     Text format     Abstract available


    December 2016
  2. MOLLAOGLU G, Guthrie MR, Bohm S, Bragelmann J, et al
    MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
    Cancer Cell. 2016 Dec 31. pii: S1535-6108(16)30600.
    PubMed     Text format     Abstract available


    July 2016
  3. BERGER AH, Brooks AN, Wu X, Shrestha Y, et al
    High-throughput Phenotyping of Lung Cancer Somatic Mutations.
    Cancer Cell. 2016 Jul 28. pii: S1535-6108(16)30282.
    PubMed     Text format     Abstract available


  4. SAHA S, Biswas SK
    Tumor-Associated Neutrophils Show Phenotypic and Functional Divergence in Human Lung Cancer.
    Cancer Cell. 2016;30:11-3.
    PubMed     Text format     Abstract available


    June 2016
  5. SINGHAL S, Bhojnagarwala PS, O'Brien S, Moon EK, et al
    Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.
    Cancer Cell. 2016 Jun 30. pii: S1535-6108(16)30226.
    PubMed     Text format     Abstract available


    May 2016
  6. BRADY JJ, Chuang CH, Greenside PG, Rogers ZN, et al
    An Arntl2-Driven Secretome Enables Lung Adenocarcinoma Metastatic Self-Sufficiency.
    Cancer Cell. 2016;29:697-710.
    PubMed     Text format     Abstract available


    April 2016
  7. FORTIN J, Mak TW
    Targeting PI3K Signaling in Cancer: A Cautionary Tale of Two AKTs.
    Cancer Cell. 2016;29:429-31.
    PubMed     Text format     Abstract available


  8. FREED DM, Park JH, Radhakrishnan R, Lemmon MA, et al
    Deletion Mutations Keep Kinase Inhibitors in the Loop.
    Cancer Cell. 2016;29:423-5.
    PubMed     Text format     Abstract available


  9. HALAMA N, Zoernig I, Berthel A, Kahlert C, et al
    Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
    Cancer Cell. 2016;29:587-601.
    PubMed     Text format     Abstract available


  10. WANG Q, Yu WN, Chen X, Peng XD, et al
    Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms.
    Cancer Cell. 2016;29:523-35.
    PubMed     Text format     Abstract available


    March 2016
  11. ALI SA, Justilien V, Jamieson L, Murray NR, et al
    Protein Kinase Ciota Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma.
    Cancer Cell. 2016;29:367-78.
    PubMed     Text format     Abstract available


    January 2016
  12. SERRESI M, Gargiulo G, Proost N, Siteur B, et al
    Polycomb Repressive Complex 2 Is a Barrier to KRAS-Driven Inflammation and Epithelial-Mesenchymal Transition in Non-Small-Cell Lung Cancer.
    Cancer Cell. 2016;29:17-31.
    PubMed     Text format     Abstract available


    September 2015
  13. WANG X, Zhao X, Feng C, Weinstein A, et al
    IL-36gamma Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.
    Cancer Cell. 2015;28:296-306.
    PubMed     Text format     Abstract available


    July 2015
  14. STEWART CA, Byers LA
    Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition.
    Cancer Cell. 2015;28:4-6.
    PubMed     Text format     Abstract available


  15. TOPHAM C, Tighe A, Ly P, Bennett A, et al
    MYC Is a Major Determinant of Mitotic Cell Fate.
    Cancer Cell. 2015;28:129-40.
    PubMed     Text format     Abstract available


  16. MOHAMMAD HP, Smitheman KN, Kamat CD, Soong D, et al
    A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.
    Cancer Cell. 2015;28:57-69.
    PubMed     Text format     Abstract available


    June 2015
  17. POLITI K, Ayeni D, Lynch T
    The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic.
    Cancer Cell. 2015;27:751-3.
    PubMed     Text format     Abstract available


    May 2015
  18. HAN B, Park D, Li R, Xie M, et al
    Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
    Cancer Cell. 2015 May 20. pii: S1535-6108(15)00143.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: